Literature DB >> 24797422

Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides.

François Spertini1, Yannick Perrin2, Régine Audran2, Céline Pellaton2, Caroline Boudousquié2, Nathalie Barbier2, Anne-Christine Thierry2, Vincent Charlon3, Christophe Reymond4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24797422     DOI： 10.1016/j.jaci.2014.04.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  25 in total

Review 1.  [Innovative forms of specific immunotherapy].

Authors:  P Zieglmayer
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

Review 2.  New strategies for allergen T cell epitope identification: going beyond IgE.

Authors:  Véronique Schulten; Bjoern Peters; Alessandro Sette
Journal:  Int Arch Allergy Immunol       Date:  2014-11-15       Impact factor: 2.749

Review 3.  Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.

Authors:  Hardik D Patel; Jeffrey M Chambliss; Meera R Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2017-08-18       Impact factor: 4.806

Review 4.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 5.  Modified Allergens for Immunotherapy.

Authors:  Pattraporn Satitsuksanoa; Anna Głobińska; Kirstin Jansen; Willem van de Veen; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

Review 6.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

7.  Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.

Authors:  Cezmi A Akdis; Mübeccel Akdis
Journal:  World Allergy Organ J       Date:  2015-05-14       Impact factor: 4.084

Review 8.  Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.

Authors:  Rudolf Valenta; Raffaela Campana; Margit Focke-Tejkl; Verena Niederberger
Journal:  J Allergy Clin Immunol       Date:  2016-02       Impact factor: 10.793

9.  Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.

Authors:  Raffaela Campana; Katharina Moritz; Katharina Marth; Angela Neubauer; Hans Huber; Rainer Henning; Katharina Blatt; Gregor Hoermann; Tess M Brodie; Alexandra Kaider; Peter Valent; Federica Sallusto; Stefan Wöhrl; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2015-10-28       Impact factor: 10.793

10.  Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.

Authors:  Petra Zieglmayer; Margarete Focke-Tejkl; René Schmutz; Patrick Lemell; René Zieglmayer; Milena Weber; Renata Kiss; Katharina Blatt; Peter Valent; Frank Stolz; Hans Huber; Angela Neubauer; Anette Knoll; Friedrich Horak; Rainer Henning; Rudolf Valenta
Journal:  EBioMedicine       Date:  2016-08-20       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.